Amy Mai

Ms. Amy Mai


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
AMAmy Mai
Amy Mai
KCKumaraswamy Naidu Chitrala
Kumaraswamy Naidu Chitrala
Disparities in breast cancer between African American (AA) and European American (EA) women persist. However, it remains unclear whether endocrine-disrupting chemicals (EDCs), including 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and bisphenol A (BPA), are associated with different gene regulatory patterns across ancestry groups. We used a multi-module network toxicology approach to assess whether EDC-associated genes in breast cancer have similar expression patterns in AA and EA patients. Intersecting EDC targets with breast cancer-associated genes in the Comparative Toxicogenomics Database identified 9,588 candidate genes, and protein–protein interaction analysis revealed ten hub genes. In TCGA-BRCA data (AA n = 189; EA n = 867), three hub genes were significantly downregulated in AA patients: ESR1 (padj = 4.03×10⁻⁹), EP300 (padj = 1.13×10⁻¹³), and ARID1A (padj = 2.14×10⁻⁸). These genes were enriched in chromatin remodeling and estrogen response processes. Transcription factor analysis identified TP53, the most central hub gene, as a high-confidence activator of ESR1. These associative findings suggest that EDC-linked gene expression varies by ancestry and identify the TP53–ESR1 axis as a candidate mechanism that requires experimental validation. They also highlight the need for ancestry-stratified analyses in environmental chemical research.